HFR Fribourg - Hopital Cantonal

Fribourg Switzerland

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myeloid, Acute

Studies at this site

• A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy — Running, not enrolling